Verein Pharmaceuticals Private Limited
Pharmaceutical trading and distribution since 2006.
2006 | Delhi (India) | Active
Verein Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -27.98%
- Profit Growth 104.00%
- Ebitda 105.30%
- Net Worth 19.68%
- Total Assets -14.85%
About Verein Pharmaceuticals
Verein Pharmaceuticals Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 March 2006 and has a history of 18 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Sethi, Pradeep Sharma, and Pran Thakur serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231DL2006PTC147080
- Company No.
147080
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2006
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
What products or services does Verein Pharmaceuticals Private Limited offer?
Verein Pharmaceuticals Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Pain Relief Spray.
Who are the key members and board of directors at Verein Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Sethi  | Director | 03-Mar-2006 | Current |
| Pradeep Sharma | Director | 03-Mar-2006 | Current |
| Pran Thakur | Director | 15-Feb-2007 | Current |
Financial Performance of Verein Pharmaceuticals.
Verein Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 27.98% decrease. The company also saw a substantial improvement in profitability, with a 104% increase in profit. The company's net worth Soared by an impressive increase of 19.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Verein Pharmaceuticals?
In 2020, Verein Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Verein Pharmaceuticals?
Unlock and access historical data on people associated with Verein Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Verein Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Verein Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.